BID | 25.64 | ASK | 26.83 | ||
Open | 26.08 | Previous Close | 26.09 | ||
Pre-Market | - | After-Market | 26.18 | ||
- - | - -% |
Target Price | 44.75 | Analyst Rating | Strong Buy 1.30 | |
Potential % | 70.93 | Finscreener Ranking | ★★★★ 52.94 | |
Insiders Trans % 3/6/12 mo. | -/-100/-100 | Value Ranking | ★★+ 48.28 | |
Insiders Value % 3/6/12 mo. | -/-100/-100 | Growth Ranking | ★★ 46.23 | |
Insiders Shares Cnt. % 3/6/12 mo. | -/-100/-100 | Income Ranking | — - | |
Price Range Ratio 52W % | 26.93 | Earnings Rating | Strong Sell | |
Market Cap | 2.96B | Earnings Date | 1st Nov 2023 | |
Alpha | 0.00 | Standard Deviation | 0.18 | |
Beta | 1.48 |
Today's Price Range 25.7926.31 | 52W Range 21.8337.98 | 5 Year PE Ratio Range -12.80-4.60 |
Summary:
Sell
Technical Indicators: | Neutral |
Moving Averages: | Strong Sell |
Performance | |||
---|---|---|---|
1 Week | -2.65% | ||
1 Month | 0.04% | ||
3 Months | -13.26% | ||
6 Months | -16.49% | ||
1 Year | -30.26% | ||
3 Years | 110.57% | ||
5 Years | -0.84% | ||
10 Years | - |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | -15.13 | |||
ROE last 12 Months | -1.96 | |||
ROA (5Y Avg) | -9.92 | |||
ROA last 12 Months | -0.95 | |||
ROC (5Y Avg) | -11.88 | |||
ROC last 12 Months | -0.41 | |||
Return on invested Capital Q | 0.64 | |||
Return on invested Capital Y | -0.11 | |||
Assets Turnover | 0.70 | |||
Receivables Turnover | 6.50 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
-169.40 | ||||
3.20 | ||||
2.90 | ||||
126.80 | ||||
-32.00 | ||||
0.21 | ||||
-8.62 | ||||
8.46 | ||||
3.06B | ||||
Forward PE | 30.25 | |||
PEG | - |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.90 | ||||
1.00 | ||||
0.35 | ||||
0.56 | ||||
-2.20 | ||||
Leverage Ratio | 2.10 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
26.10 | ||||
-2.80 | ||||
2.40 | ||||
-21.20 | ||||
-0.81 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
969.58M | ||||
9.58 | ||||
9.10 | ||||
23.80 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q02 2023 | -0.01 | 0.06 | 700.00 |
Q01 2023 | 0.04 | 0.11 | 175.00 |
Q04 2022 | -0.02 | -0.04 | -100.00 |
Q03 2022 | 0.00 | 0.52 | - |
Q02 2022 | -0.05 | 0.02 | 140.00 |
Q01 2022 | -0.08 | 0.06 | 175.00 |
Q04 2021 | -0.06 | 0.02 | 133.33 |
Q03 2021 | -0.08 | -0.08 | 0.00 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
9/2023 QR | -0.01 | -200.00 | Negative |
12/2023 QR | 0.00 | -100.00 | Negative |
12/2023 FY | 0.31 | 933.33 | Positive |
12/2024 FY | 0.90 | 500.00 | Positive |
Next Report Date | 1st Nov 2023 |
Estimated EPS Next Report | -0.01 |
Estimates Count | 1 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 586.75K |
Shares Outstanding | 113.24K |
Shares Float | 107.17M |
Trades Count | 8.66K |
Dollar Volume | 15.36M |
Avg. Volume | 843.46K |
Avg. Weekly Volume | 737.98K |
Avg. Monthly Volume | 893.57K |
Avg. Quarterly Volume | 898.82K |
Evolent Health Inc Class A (NYSE: EVH) stock closed at 26.09 per share at the end of the most recent trading day (a -3.05% change compared to the prior day closing price) with a volume of 623.42K shares and market capitalization of 2.96B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 2900 people. Evolent Health Inc Class A CEO is Seth Blackley.
The one-year performance of Evolent Health Inc Class A stock is -30.26%, while year-to-date (YTD) performance is -7.09%. EVH stock has a five-year performance of -0.84%. Its 52-week range is between 21.8322 and 37.9799, which gives EVH stock a 52-week price range ratio of 26.93%
Evolent Health Inc Class A currently has a PE ratio of -169.40, a price-to-book (PB) ratio of 3.20, a price-to-sale (PS) ratio of 2.90, a price to cashflow ratio of 126.80, a PEG ratio of -, a ROA of -0.95%, a ROC of -0.41% and a ROE of -1.96%. The company’s profit margin is -0.81%, its EBITDA margin is 2.40%, and its revenue ttm is $969.58 Million , which makes it $9.58 revenue per share.
Of the last four earnings reports from Evolent Health Inc Class A, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.01 for the next earnings report. Evolent Health Inc Class A’s next earnings report date is 01st Nov 2023.
The consensus rating of Wall Street analysts for Evolent Health Inc Class A is Strong Buy (1.3), with a target price of $44.75, which is +70.93% compared to the current price. The earnings rating for Evolent Health Inc Class A stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Evolent Health Inc Class A has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Evolent Health Inc Class A has a Sell technical analysis rating based on Technical Indicators (ADX : 11.60, ATR14 : 0.74, CCI20 : -10.42, Chaikin Money Flow : -0.01, MACD : 0.00, Money Flow Index : 71.31, ROC : -0.42, RSI : 44.18, STOCH (14,3) : 15.34, STOCH RSI : 0.00, UO : 50.61, Williams %R : -84.66), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Evolent Health Inc Class A in the last 12-months were: Blackley Seth (Option Excercise at a value of $426 394), Blackley Seth (Option Exercise at a value of $126 762), Blackley Seth (Sold 313 034 shares of value $10 223 589 ), Daniel Joseph Mccarthy (Sold 1 000 shares of value $31 440 ), Frank J. Williams (Option Excercise at a value of $3 173 548), Frank J. Williams (Sold 866 667 shares of value $27 347 420 ), Holder Diane (Sold 12 000 shares of value $375 120 ), Scott Cheryl (Sold 2 365 shares of value $70 974 ), Seth Blackley (Option Excercise at a value of $288 000), Seth Blackley (Sold 243 983 shares of value $7 844 404 ), Williams Frank (Option Excercise at a value of $4 149 344), Williams Frank (Sold 866 667 shares of value $28 248 448 ), WILLIAMS FRANK J (Option Exercise at a value of $1 064 896), WILLIAMS FRANK J (Sold 110 000 shares of value $3 247 108 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. The company's reportable segments are Service segment which includes value-based care services, specialty care management services and comprehensive health plan administration services. and True Health segment consists of a commercial health plan it operates in New Mexico that focuses on small and large businesses. It generates a majority of its revenue from the Service segment.
CEO: Seth Blackley
Telephone: +1 571 389-6000
Address: 800 N. Glebe Road, Arlington 22203, VA, US
Number of employees: 2 900
Wed, 09 Aug 2023 02:25 GMT Evolent Health (EVH) Gets a Hold from Truist Financial
- TipRanks. All rights reserved.Sat, 05 Aug 2023 01:51 GMT Analysts Are Bullish on Top Healthcare Stocks: Evolent Health (EVH), Karuna Therapeutics (KRTX)
- TipRanks. All rights reserved.Sun, 16 Jul 2023 13:50 GMT Analysts Opinions Are Mixed on These Healthcare Stocks: Evolent Health (EVH), Lucid Group (LCID) and UnitedHealth (UNH)
- TipRanks. All rights reserved.Fri, 07 Jul 2023 01:45 GMT Evolent Health (EVH) Receives a Buy from RBC Capital
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.